{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:53:14Z","timestamp":1783608794432,"version":"3.55.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s11882-020-00926-4","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T12:02:41Z","timestamp":1591790561000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Proton Pump Inhibitors in Children: the Good, the Bad, and the Ugly"],"prefix":"10.1007","volume":"20","author":[{"given":"Eric A.","family":"Pasman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire P.","family":"Witmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4543-6804","authenticated-orcid":false,"given":"Cade M.","family":"Nylund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,10]]},"reference":[{"issue":"4","key":"926_CR1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/MPG.0b013e31812e0149","volume":"45","author":"JJ Barron","year":"2007","unstructured":"Barron JJ, Tan H, Spalding J, Bakst AW, Singer J. Proton pump inhibitor utilization patterns in infants. J Pediatr Gastroenterol Nutr. 2007;45(4):421\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"926_CR2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/archdischild-2017-314026","volume":"103","author":"P De Bruyne","year":"2018","unstructured":"De Bruyne P, Ito S. Toxicity of long-term use of proton pump inhibitors in children. Arch Dis Child. 2018;103(1):78\u201382.","journal-title":"Arch Dis Child"},{"issue":"1","key":"926_CR3","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2625","volume":"144","author":"L Malchodi","year":"2019","unstructured":"Malchodi L, Wagner K, Susi A, Gorman G, Hisle-Gorman E. Early acid suppression therapy exposure and fracture in young children. Pediatrics. 2019;144(1):e20182625.","journal-title":"Pediatrics."},{"issue":"1","key":"926_CR4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jaci.2017.06.017","volume":"141","author":"R Yadlapati","year":"2018","unstructured":"Yadlapati R, Kahrilas PJ. The \u201cdangers\u201d of chronic proton pump inhibitor use. J Allergy Clin Immunol. 2018;141(1):79\u201381.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"926_CR5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1053\/j.gastro.2017.01.031","volume":"152","author":"DE Freedberg","year":"2017","unstructured":"Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017;152(4):706\u201315.","journal-title":"Gastroenterology."},{"issue":"4","key":"926_CR6","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","volume":"155","author":"ES Dellon","year":"2018","unstructured":"\u2022\u2022 Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference. Gastroenterology. 2018;155(4):1022\u201333.e10. Most recent EoE guidelines.","journal-title":"Gastroenterology"},{"issue":"5","key":"926_CR7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.23736\/S0026-4806.18.05705-1","volume":"109","author":"V Savarino","year":"2018","unstructured":"Savarino V, Marabotto E, Zentilin P, Furnari M, Bodini G, De Maria C, et al. The appropriate use of proton-pump inhibitors. Minerva Med. 2018;109(5):386\u201399.","journal-title":"Minerva Med"},{"key":"926_CR8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jpeds.2015.08.064","volume":"168","author":"CM Stark","year":"2016","unstructured":"Stark CM, Nylund CM. Side effects and complications of proton pump inhibitors: a pediatric perspective. J Pediatr. 2016;168:16\u201322.","journal-title":"J Pediatr"},{"issue":"1","key":"926_CR9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1542\/hpeds.2012-0077","volume":"3","author":"EY Chung","year":"2013","unstructured":"Chung EY, Yardley J. Are there risks associated with empiric acid suppression treatment of infants and children suspected of having gastroesophageal reflux disease? Hosp Pediatr. 2013;3(1):16\u201323.","journal-title":"Hosp Pediatr"},{"issue":"2","key":"926_CR10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/bcp.12619","volume":"80","author":"S Cohen","year":"2015","unstructured":"Cohen S, Bueno de Mesquita M, Mimouni FB. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review. Br J Clin Pharmacol. 2015;80(2):200\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"926_CR11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MPG.0000000000001889","volume":"66","author":"R Rosen","year":"2018","unstructured":"\u2022\u2022 Rosen R, Vandenplas Y, Singendonk M, Cabana M, DiLorenzo C, Gottrand F, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66(3):516\u201354. NASPGHAN guideline with age-based algorithm for GERD management.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"926_CR12","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/apa.15027","volume":"109","author":"N Helin","year":"2020","unstructured":"Helin N, Kolho K, Rintala R, Merras-Salmio L. Upper endoscopy for non-acute non-specific symptoms is seldom beneficial for children under the age of seven. Acta Paediatr. 2020;109(4):827\u201335.","journal-title":"Acta Paediatr"},{"issue":"8","key":"926_CR13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00383-019-04490-5","volume":"35","author":"T Saito","year":"2019","unstructured":"Saito T, Uesato M, Terui K, Nakata M, Komatsu S, Yoshida H. Acid and bolus exposure in pediatric reflux disease according to the presence and severity of esophageal mucosal lesions. Pediatr Surg Int. 2019;35(8):887\u201393.","journal-title":"Pediatr Surg Int"},{"key":"926_CR14","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/01.mpg.0000469419.29000.94","volume":"60","author":"V Tolia","year":"2015","unstructured":"Tolia V, Youssef NN, Gilger MA, Traxler B, Illueca M. Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study. J Pediatr Gastroenterol Nutr. 2015;60:S24\u201330.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"926_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2011.02.040","volume":"128","author":"CA Liacouras","year":"2011","unstructured":"Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128(1):3\u201320.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"926_CR16","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11882-017-0721-2","volume":"17","author":"MA Ruffner","year":"2017","unstructured":"Ruffner MA, Spergel JM. Eosinophilic esophagitis in children. Curr Allergy Asthma Rep. 2017;17(8):54.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"6","key":"926_CR17","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0016-5085(77)80034-6","volume":"72","author":"JW Dobbins","year":"1977","unstructured":"Dobbins JW, Sheahan DG, Behar J. Eosinophilic gastroenteritis with esophageal involvement. Gastroenterology. 1977;72(6):1312\u20136.","journal-title":"Gastroenterology."},{"issue":"2","key":"926_CR18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/j.gastro.2017.06.067","volume":"154","author":"ES Dellon","year":"2018","unstructured":"Dellon ES, Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology. 2018;154(2):319\u201332.","journal-title":"Gastroenterology."},{"key":"926_CR19","doi-asserted-by":"crossref","unstructured":"Shaheen NJ, Mukkada V, Eichinger CS, Schofield H, Todorova L, Falk GW. Natural history of eosinophilic esophagitis: a systematic review ofepidemiology and disease course. Dis Esophagus. 2018;31(8):doy015.","DOI":"10.1093\/dote\/doy015"},{"issue":"11","key":"926_CR20","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/ppul.24168","volume":"53","author":"E Rubinstein","year":"2018","unstructured":"Rubinstein E, Rosen R. Respiratory symptoms associated with eosinophilic esophagitis. Pediatr Pulmonol. 2018;53(11):1587\u201391.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"926_CR21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cgh.2015.07.041","volume":"14","author":"AJ Lucendo","year":"2016","unstructured":"Lucendo AJ, Arias \u00c1, Molina-Infante J. Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2016;14(1):13\u201322.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"926_CR22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/MCG.0000000000000621","volume":"51","author":"SB Min","year":"2017","unstructured":"Min SB, Nylund CM, Baker TP, Ally M, Reinhardt B, Chen YJ, et al. Longitudinal evaluation of noninvasive biomarkers for eosinophilic esophagitis. J Clin Gastroenterol. 2017;51(2):127\u201335.","journal-title":"J Clin Gastroenterol"},{"issue":"12","key":"926_CR23","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.cgh.2014.06.019","volume":"12","author":"ES Dellon","year":"2014","unstructured":"Dellon ES, Speck O, Woodward K, Covey S, Rusin S, Gebhart JH, et al. Markers of eosinophilic inflammation for diagnosis of eosinophilic esophagitis and proton pump inhibitor-responsive esophageal eosinophilia: a prospective study. Clin Gastroenterol Hepatol. 2014;12(12):2015\u201322.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"926_CR24","doi-asserted-by":"crossref","first-page":"e101391","DOI":"10.1371\/journal.pone.0101391","volume":"9","author":"JY Park","year":"2014","unstructured":"Park JY, Zhang X, Nguyen N, Souza RF, Spechler SJ, Cheng E. Proton pump inhibitors decrease eotaxin-3 expression in the proximal esophagus of children with esophageal eosinophilia. PLoS One. 2014;9(7):e101391.","journal-title":"PLoS One"},{"issue":"8","key":"926_CR25","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/apt.12914","volume":"40","author":"J Molina-Infante","year":"2014","unstructured":"Molina-Infante J, Rivas MD, Hernandez-Alonso M, Vinagre-Rodr\u00edguez G, Mateos-Rodr\u00edguez JM, Due\u00f1as-Sadornil C, et al. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression. Aliment Pharmacol Ther. 2014;40(8):955\u201365.","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"926_CR26","doi-asserted-by":"crossref","first-page":"e50037","DOI":"10.1371\/journal.pone.0050037","volume":"7","author":"X Zhang","year":"2012","unstructured":"Zhang X, Cheng E, Huo X, Yu C, Zhang Q, Pham TH, et al. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS One. 2012;7(11):e50037.","journal-title":"PLoS One"},{"issue":"6","key":"926_CR27","doi-asserted-by":"crossref","first-page":"e0157376","DOI":"10.1371\/journal.pone.0157376","volume":"11","author":"E Cheng","year":"2016","unstructured":"Cheng E, Zhang X, Wilson KS, Wang DH, Park JY, Huo X, et al. JAK-STAT6 pathway inhibitors block eotaxin-3 secretion by epithelial cells and fibroblasts from esophageal eosinophilia patients: promising agents to improve inflammation and prevent fibrosis in EoE. PLoS One. 2016;11(6):e0157376.","journal-title":"PLoS One"},{"issue":"12","key":"926_CR28","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1177\/0009922811412585","volume":"50","author":"JM Garza","year":"2011","unstructured":"Garza JM, Nylund CM, Kaul A. Time to stop blaming gastroesophageal reflux. Clin Pediatr (Phila). 2011;50(12):1110\u20135.","journal-title":"Clin Pediatr (Phila)"},{"issue":"4","key":"926_CR29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jpeds.2008.09.054","volume":"154","author":"SR Orenstein","year":"2009","unstructured":"Orenstein SR, Hassall E, Furmaga-Jablonska W, Atkinson S, Raanan M. Multicenter, double-blind, randomized, placebo-controlled trial assessing the efficacy and safety of proton pump inhibitor lansoprazole in infants with symptoms of gastroesophageal reflux disease. J Pediatr. 2009;154(4):514\u201320.","journal-title":"J Pediatr"},{"issue":"2","key":"926_CR30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/MPG.0b013e3182a3b04e","volume":"58","author":"P De Bruyne","year":"2014","unstructured":"De Bruyne P, Christiaens T, Vander Stichele R, Van Winckel M. Changes in prescription patterns of acid-suppressant medications by Belgian pediatricians: analysis of the national database, [1997-2009]. J Pediatr Gastroenterol Nutr. 2014;58(2):220\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"926_CR31","volume":"98","author":"X Chen","year":"2019","unstructured":"Chen X, Peng WS, Wang L. Etiology analysis of nonspecific chronic cough in children of 5 years and younger. Medicine (Baltimore). 2019;98(3):e13910.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"926_CR32","first-page":"23","volume":"1","author":"DJ Adamko","year":"2012","unstructured":"Adamko DJ, Majaesic CM, Skappak C, Jones AB. A pilot trial on the treatment of gastroesophageal reflux-related cough in infants. Transl Pediatr. 2012;1(1):23\u201334.","journal-title":"Transl Pediatr"},{"issue":"4","key":"926_CR33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/jama.2011.2035","volume":"307","author":"JT Holbrook","year":"2012","unstructured":"Holbrook JT, Wise RA, Gold BD, Blake K, Brown ED, Castro M, et al. Randomized clinical trial of lansoprazole for poorly controlled asthma in children: the American Lung Association Asthma Clinical Research Centers. JAMA. 2012;307(4):373\u201381.","journal-title":"JAMA."},{"issue":"12","key":"926_CR34","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/jamaoto.2018.1919","volume":"144","author":"DR Duncan","year":"2018","unstructured":"\u2022 Duncan DR, Mitchell PD, Larson K, ME MS, Rosen RL. Association of PPI with hospitalization risk in children with oropharyngeal dysphagia. JAMA Otolaryngol Head Neck Surg. 2018;144(12):1116\u201324. Excellent article from an aerodigestive clinic experience discussing association between PPI use and hospitalization risk.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"926_CR35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.chest.2019.03.035","volume":"156","author":"AB Chang","year":"2019","unstructured":"\u2022 Chang AB, Oppenheimer JJ, Kahrilas PJ, Kantar A, Rubin BK, Weinberger M, et al. Chronic cough and gastroesophageal reflux in children: chest guideline and expert panel report. Chest. 2019;156(1):131\u201340. Guidelines from CHEST for testing and management of cough and GERD in children.","journal-title":"Chest"},{"key":"926_CR36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijporl.2018.10.017","volume":"116","author":"MS Fracchia","year":"2019","unstructured":"Fracchia MS, Diercks G, Cook A, Hersh C, Hardy S, Hartnick M, et al. The diagnostic role of triple endoscopy in pediatric patients with chronic cough. Int J Pediatr Otorhinolaryngol. 2019;116:58\u201361.","journal-title":"Int J Pediatr Otorhinolaryngol"},{"issue":"343","key":"926_CR37","doi-asserted-by":"crossref","first-page":"343ra82","DOI":"10.1126\/scitranslmed.aad7121","volume":"8","author":"NA Bokulich","year":"2016","unstructured":"Bokulich NA, Chung J, Battaglia T, Henderson N, Jay M, Li H, et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med. 2016;8(343):343ra82.","journal-title":"Sci Transl Med"},{"issue":"1","key":"926_CR38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/imr.12185","volume":"260","author":"LM Kato","year":"2014","unstructured":"Kato LM, Kawamoto S, Maruya M, Fagarasan S. The role of the adaptive immune system in regulation of gut microbiota. Immunol Rev. 2014;260(1):67\u201375.","journal-title":"Immunol Rev"},{"issue":"3","key":"926_CR39","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/ismej.2014.165","volume":"9","author":"H Zhang","year":"2015","unstructured":"Zhang H, Sparks JB, Karyala SV, Settlage R, Luo XM. Host adaptive immunity alters gut microbiota. ISME J. 2015;9(3):770\u201381.","journal-title":"ISME J"},{"issue":"5","key":"926_CR40","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/gutjnl-2015-310376","volume":"65","author":"F Imhann","year":"2016","unstructured":"Imhann F, Bonder MJ, Vich Vila A, Fu J, Mujagic Z, Vork L, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016;65(5):740\u20138.","journal-title":"Gut."},{"issue":"4","key":"926_CR41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/j.gastro.2015.06.043","volume":"149","author":"DE Freedberg","year":"2015","unstructured":"Freedberg DE, Toussaint NC, Chen SP, Ratner AJ, Whittier S, Wang TC, et al. Proton pump inhibitors alter specific taxa in the human gastrointestinal microbiome: a crossover trial. Gastroenterology. 2015;149(4):883\u20135.","journal-title":"Gastroenterology."},{"issue":"6","key":"926_CR42","first-page":"489","volume":"24","author":"NRM Schwartz","year":"2019","unstructured":"Schwartz NRM, Hutfless S, Herrinton LJ, Amsden LB, Fevrier HB, Giefer M, et al. Proton pump inhibitors, H2 blocker use, and risk of inflammatory bowel disease in children. J Pediatr Pharmacol Ther. 2019;24(6):489\u201396.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"5","key":"926_CR43","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.chom.2017.10.005","volume":"22","author":"P Maruvada","year":"2017","unstructured":"Maruvada P, Leone V, Kaplan LM, Chang EB. The human microbiome and obesity: moving beyond associations. Cell Host Microbe. 2017;22(5):589\u201399.","journal-title":"Cell Host Microbe"},{"issue":"1","key":"926_CR44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/gutjnl-2017-314971","volume":"68","author":"CM Stark","year":"2018","unstructured":"Stark CM, Susi A, Emerick J, Nylund CM. Antibiotic and acid-suppression medications during early childhood are associated with obesity. Gut. 2018;68(1):62\u20139.","journal-title":"Gut."},{"issue":"11","key":"926_CR45","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2036.2011.04874.x","volume":"34","author":"C Bavishi","year":"2011","unstructured":"Bavishi C, Dupont HL. Systematic review: the use of proton pump inhibitors and increased susceptibility to enteric infection. Aliment Pharmacol Ther. 2011;34(11):1269\u201381.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"926_CR46","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1128\/IAI.01138-07","volume":"76","author":"SM Tennant","year":"2008","unstructured":"Tennant SM, Hartland EL, Phumoonna T, Lyras D, Rood JI, Robins-Browne RM, et al. Influence of gastric acid on susceptibility to infection with ingested bacterial pathogens. Infect Immun. 2008;76(2):639\u201345.","journal-title":"Infect Immun"},{"issue":"9","key":"926_CR47","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1007\/s10620-009-1076-x","volume":"55","author":"M Sanaka","year":"2010","unstructured":"Sanaka M, Yamamoto T, Kuyama Y. Effects of proton pump inhibitors on gastric emptying: a systematic review. Dig Dis Sci. 2010;55(9):2431\u201340.","journal-title":"Dig Dis Sci"},{"key":"926_CR48","unstructured":"FDA. Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs). RDA Drug Safety Communication. 2012. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-clostridium-difficile-associated-diarrhea-can-be-associated-stomach. Accessed 03 Apr 2020."},{"issue":"35","key":"926_CR49","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.3748\/wjg.v23.i35.6500","volume":"23","author":"A Trifan","year":"2017","unstructured":"Trifan A, Stanciu C, Girleanu I, Stoica OC, Singeap AM, Maxim R, et al. Proton pump inhibitors therapy and risk of Clostridium difficile infection: systematic review and meta-analysis. World J Gastroenterol. 2017;23(35):6500\u201315.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"926_CR50","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1017\/ice.2019.23","volume":"40","author":"S Anjewierden","year":"2019","unstructured":"\u2022\u2022 Anjewierden S, Han Z, Foster CB, Pant C, Deshpande A. Risk factors for Clostridium difficile infection in pediatric inpatients: a meta-analysis and systematic review. Infect Control Hosp Epidemiol. 2019;40(4):420\u20136. Meta-analysis of over 10,000 cases demonstrating increased odds forClostridium difficileinfection when PPI is prescribed to children.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"926_CR51","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.cgh.2007.09.010","volume":"5","author":"LA Garcia Rodriguez","year":"2007","unstructured":"Garcia Rodriguez LA, Ruigomez A, Pan\u00e9s J. Use of acid-suppressing drugs and the risk of bacterial gastroenteritis. Clin Gastroenterol Hepatol. 2007;5(12):1419\u201323.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7636","key":"926_CR52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/bmj.39458.465845.3A","volume":"336","author":"J Thachil","year":"2008","unstructured":"Thachil J. Overprescribing PPIs: time for a hospital antacid policy on Clostridium difficile. BMJ. 2008;336(7636):109.","journal-title":"BMJ."},{"issue":"8","key":"926_CR53","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1017\/S0950268817000528","volume":"145","author":"C Prag","year":"2017","unstructured":"Prag C, Prag M, Fredlund H. Proton pump inhibitors as a risk factor for norovirus infection. Epidemiol Infect. 2017;145(8):1617\u201323.","journal-title":"Epidemiol Infect"},{"issue":"11","key":"926_CR54","doi-asserted-by":"crossref","first-page":"e1916205","DOI":"10.1001\/jamanetworkopen.2019.16205","volume":"2","author":"AM Vilcu","year":"2019","unstructured":"Vilcu AM, Sabatte L, Blanchon T, Souty C, Maravic M, Lemaitre M, et al. Association between acute gastroenteritis and continuous use of proton pump inhibitors during winter periods of highest circulation of enteric viruses. JAMA Netw Open. 2019;2(11):e1916205.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"926_CR55","doi-asserted-by":"crossref","first-page":"e0128004","DOI":"10.1371\/journal.pone.0128004","volume":"10","author":"AA Lambert","year":"2015","unstructured":"Lambert AA, Lam JO, Paik JJ, Ugarte-Gil C, Drummond MB, Crowell TA. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and meta-analysis. PLoS One. 2015;10(6):e0128004.","journal-title":"PLoS One"},{"issue":"7","key":"926_CR56","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1111\/jgs.15385","volume":"66","author":"J Zirk-Sadowski","year":"2018","unstructured":"Zirk-Sadowski J, Masoli JA, Delgado J, Hamilton W, Strain WD, Henley W, et al. Proton-pump inhibitors and long-term risk of community-acquired pneumonia in older adults. J Am Geriatr Soc. 2018;66(7):1332\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"926_CR57","doi-asserted-by":"crossref","first-page":"e817","DOI":"10.1542\/peds.2005-1655","volume":"117","author":"RB Canani","year":"2006","unstructured":"Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, et al. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics. 2006;117(5):e817\u201320.","journal-title":"Pediatrics."},{"issue":"1","key":"926_CR58","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1097\/MPG.0000000000002175","volume":"68","author":"CA Velasco-Benitez","year":"2019","unstructured":"\u2022\u2022 Velasco-Benitez CA. Proton pump inhibitors and infant pneumonia\/other lower respiratory tract infections: national nested case-control study. J Pediatr Gastroenterol Nutr. 2019;68(1):e19. Pediatric data on CAP and PPI is sparse, but this 2019 case-control study of 631 infants found no assocation between PPI use and respiratory tract infections.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"926_CR59","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00198-017-4262-2","volume":"29","author":"SM Lin","year":"2018","unstructured":"Lin SM, Yang SH, Liang CC, Huang HK. Proton pump inhibitor use and the risk of osteoporosis and fracture in stroke patients: a population-based cohort study. Osteoporos Int. 2018;29(1):153\u201362.","journal-title":"Osteoporos Int"},{"key":"926_CR60","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/RMHP.S223118","volume":"12","author":"MR Fattahi","year":"2019","unstructured":"Fattahi MR, Niknam NR, Shams M, Anushiravani A, Taghavi SA, Omrani GR, et al. The association between prolonged proton pump inhibitors use and bone mineral density. Risk Manag Healthc Policy. 2019;12:349\u201355.","journal-title":"Risk Manag Healthc Policy"},{"issue":"1","key":"926_CR61","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00198-018-4788-y","volume":"30","author":"TN Poly","year":"2019","unstructured":"Poly TN, Islam MM, Yang HC, Wu CC, Li YJ. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies. Osteoporos Int. 2019;30(1):103\u201314.","journal-title":"Osteoporos Int"},{"issue":"10","key":"926_CR62","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s00198-015-3168-0","volume":"26","author":"DE Freedberg","year":"2015","unstructured":"Freedberg DE, Haynes K, Denburg MR, Zemel BS, Leonard MB, Abrams JA, et al. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study. Osteoporos Int. 2015;26(10):2501\u20137.","journal-title":"Osteoporos Int"},{"issue":"3","key":"926_CR63","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11882-016-0595-8","volume":"16","author":"I Otani","year":"2016","unstructured":"Otani I, Banerji A. Immediate and delayed hypersensitivity reactions to proton pump inhibitors: evaluation and management. Curr Allergy Asthma Rep. 2016;16(3):17.","journal-title":"Curr Allergy Asthma Rep"},{"key":"926_CR64","doi-asserted-by":"crossref","unstructured":"Casciaro M, Navarra M, Inferrera G, Liotta M, Gangemi S, Minciullo PL. PPI adverse drugs reactions: a retrospective study. Clin Mol Allergy. 2019;17(1).","DOI":"10.1186\/s12948-019-0104-4"},{"issue":"9","key":"926_CR65","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.5415\/apallergy.2019.9.e30","volume":"14","author":"L Barakat","year":"2019","unstructured":"Barakat L, Vasconcelos MJ, Bourrain JL, Demoly P, Chiriac AM. IgE mediated allergy to proton pump inhibitors with both delayed and immediate onset. Asia Pac Allergy. 2019;14(9):e30.","journal-title":"Asia Pac Allergy"},{"issue":"6","key":"926_CR66","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.anai.2013.08.022","volume":"111","author":"S Bose","year":"2013","unstructured":"\u2022\u2022 Bose S, Guyer A, Long A, Banerji A. Evaluation and management of hypersensitivity to proton pump inhibitors. Ann Allergy Asthma Immunol. 2013;111(6):452\u20137. Comprehensive literature review of PPI-mediated hypersensitivity reactions includes clinical characteristics, reaction categorization, and an evidence-based algorithm for evaluation and treatment.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"926_CR67","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jaip.2015.11.029","volume":"4","author":"I Mota","year":"2016","unstructured":"Mota I, Gaspar A, Chambel M, Morais-Almeida M. Anaphylaxis induced by proton pump inhibitors. J Allergy Clin Immunol Pract. 2016;4(3):535\u20136.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"926_CR68","first-page":"76","volume":"19","author":"C Tayman","year":"2009","unstructured":"Tayman C, Mete E, Catal F, Tonbul A. Hypersensitivity reaction to omeprazole in a child. J Investig Allergol Clin Immunol. 2009;19(1):76\u20137.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"1","key":"926_CR69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/all.13235","volume":"73","author":"CY Lin","year":"2018","unstructured":"Lin CY, Wang CW, Hui CR, Chang YC, Yang CH, Cheng CY, et al. Delayed-type hypersensitivity reactions induced by proton pump inhibitors: a clinical and in vitro T-cell reactivity study. Allergy. 2018;73(1):221\u20139.","journal-title":"Allergy."},{"issue":"2","key":"926_CR70","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12016-018-8701-4","volume":"57","author":"EJ Hait","year":"2019","unstructured":"Hait EJ, McDonald DR. Impact of gastroesophageal reflux disease on mucosal immunity and atopic disorders. Clin Rev Allergy Immunol. 2019;57(2):213\u201325.","journal-title":"Clin Rev Allergy Immunol"},{"key":"926_CR71","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1038\/s41467-019-10914-6","volume":"10","author":"G Jordakieva","year":"2019","unstructured":"Jordakieva G, Kundi M, Untersmayr E, Pali-Scholl I, Reichardt B, Jensen-Jarolim E. Country-wide medical records infer increased allergy risk of gastric acid inhibition. Nat Commun. 2019;10:3298.","journal-title":"Nat Commun"},{"issue":"6","key":"926_CR72","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1096\/fj.04-3170fje","volume":"19","author":"E Untersmayr","year":"2005","unstructured":"\u2022\u2022 Untersmayr E, Bakos N, Scholl I, Kundi M, Roth-Walter F, Szalai K, et al. Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients. FASEB. 2005;19(6):656\u20138. Only study thus far to investigate relative changes and new IgE formation to foods before and after chronic PPI use, suggest PPIs may have a role in development of ingsted food sensitization.","journal-title":"FASEB"},{"issue":"6","key":"926_CR73","doi-asserted-by":"crossref","first-page":"e180315","DOI":"10.1001\/jamapediatrics.2018.0315","volume":"172","author":"E Mitre","year":"2018","unstructured":"\u2022\u2022 Mitre E, Susi A, Kropp LE, Schwartz DJ, Gorman GH, Nylund CM. Association between use of acid-suppressive medications and antibiotics during infancy and allergic diseases in early childhood. JAMA Pediatr. 2018;172(6):e180315. This 2019 study identified multiple associations between PPI use and allergic disorders in a large pediatric cohort.","journal-title":"JAMA Pediatr"},{"issue":"10","key":"926_CR74","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/j.1365-2036.2012.05073.x","volume":"35","author":"AB Andersen","year":"2012","unstructured":"Andersen AB, Erichsen R, Farkas DK, Mehnert F, Ehrenstein V, S\u00f8rensen HT. Prenatal exposure to acid-suppressive drugs and the risk of childhood asthma: a population-based Danish cohort study. Aliment Pharmacol Ther. 2012;35(10):1190\u20138.","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"926_CR75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/cea.12227","volume":"44","author":"B Mulder","year":"2014","unstructured":"Mulder B, Schulling-Veninga CC, Bos HJ, De Vries TW, Jick SS, Hak E. Prenatal exposure to acid-suppressive drugs and the risk of allergic diseases in the offspring: a cohort study. Clin Exp Allergy. 2014;44(2):261\u20139.","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"926_CR76","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/apt.13486","volume":"43","author":"L Soriano Cea","year":"2016","unstructured":"Soriano Cea L, Hernandez-Diaz S, Johansson S, Nagy P, Garcia-Rodriguez LA. Exposure to acid-suppressive drugs during pregnancy and the risk of asthma in childhood: an observational cohort study. Aliment Pharmacol Ther. 2016;43(3):427\u201337.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"926_CR77","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/jcph.574","volume":"56","author":"M Yitshak-Sade","year":"2016","unstructured":"Yitshak-Sade M, Gorodischer R, Aviram M, Novack L. Prenatal exposure to H2 blockers and to proton pump inhibitors and asthma development in offspring. J Clin Pharmacol. 2016;56(1):116\u201323.","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"926_CR78","doi-asserted-by":"crossref","first-page":"e20170889","DOI":"10.1542\/peds.2017-0889","volume":"141","author":"T Lai","year":"2018","unstructured":"\u2022 Lai T, Wu M, Liu J, Juo M, He L, Wang X, et al. Acid-suppressive drug use during risk of pregnancy and the risk of childhood asthma: a meta-analysis. Pediatrics. 2018;141(2):e20170889. Large meta-analysis identifying a significant association between maternal PPI use during pregnancy and the development of asthma in offspring.","journal-title":"Pediatrics"},{"issue":"5","key":"926_CR79","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/00003246-200205000-00026","volume":"30","author":"K Zedtwitz-Liebenstein","year":"2002","unstructured":"Zedtwitz-Liebenstein K, Wenisch C, Patruta S, Parschalk B, Daxbock F, Graninger W. Omeprazole treatment diminishes intra- and extracellular neutrophil reactive oxygen production and bactericidal activity. Crit Care Med. 2002;30(5):1118\u201322.","journal-title":"Crit Care Med"},{"key":"926_CR80","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1365-2036.2000.014s1074.x","volume":"14","author":"N Yoshida","year":"2000","unstructured":"Yoshida N, Yoshikawa T, Tanaka Y, Fujita N, Kassai K, Naito Y, et al. A new mechanism for anti-inflammatory actions of proton pump inhibitors \u2013 inhibitory effects on neutrophil-endothelial cell interactions. Aliment Pharmacol Ther. 2000;14:74\u201381.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"926_CR81","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/039463200802100109","volume":"21","author":"E Capodicasa","year":"2008","unstructured":"Capodicasa E, Comacchione P, Natalini B, Bartoli A, Coaccioli S, Marconi P, et al. Omeperazole induces apoptosis in normal human polymorphonuclear leukocytes. Int J Immunopathol Pharmacol. 2008;21(1):73\u201385.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"6","key":"926_CR82","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s10156-009-0728-2","volume":"15","author":"T Ubagai","year":"2009","unstructured":"Ubagai T, Koshibu Y, Koshio O, Nakaki T, Ono Y. Downregulation of immunomodulator gene expression in LPS-stimulated human polymorphonuclear leukocytes by the proton pump inhibitor lansoprazole. J Infect Chemother. 2009;15(6):374\u20139.","journal-title":"J Infect Chemother"},{"issue":"11","key":"926_CR83","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s10620-009-0951-9","volume":"54","author":"RR Kedika","year":"2009","unstructured":"Kedika RR, Souza RF, Spechler SJ. Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of clinical implications. Dig Dis Sci. 2009;54(11):2312\u20137.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"926_CR84","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10620-007-9869-2","volume":"53","author":"H Alkim","year":"2008","unstructured":"Alkim H, Unai S, Okur H, Imir T. Omeprazole inhibits natural killer cell functions. Dig Dis Sci. 2008;53(2):347\u201351.","journal-title":"Dig Dis Sci"},{"issue":"2","key":"926_CR85","doi-asserted-by":"crossref","first-page":"357","DOI":"10.3109\/08923979909052768","volume":"21","author":"E Capodicasa","year":"1999","unstructured":"Capodicasa E, De Bellis F, Pelli MA. Effect of lansoprazole on human leukocyte function. Immunopharmacol Immunotoxicol. 1999;21(2):357\u201377.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"8","key":"926_CR86","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1023\/A:1026604203237","volume":"44","author":"T Ohara","year":"1999","unstructured":"Ohara T, Arakawa T. Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells. Dig Dis Sci. 1999;44(8):1710\u20135.","journal-title":"Dig Dis Sci"},{"issue":"11","key":"926_CR87","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00383-006-1767-8","volume":"22","author":"A Hinoki","year":"2006","unstructured":"Hinoki A, Yoshimura K, Fujita K, Akita M, Ikeda R, Nagashima M, et al. Suppression of proinflammatory cytokine production in macrophages by lansoprazole. Pediatr Surg Int. 2006;22(11):915\u201323.","journal-title":"Pediatr Surg Int"},{"issue":"12","key":"926_CR88","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00535-013-0774-5","volume":"48","author":"W Liu","year":"2013","unstructured":"Liu W, Baker SS, Trinidad J, Burlingame AL, Baker RD, Forte JG, et al. Inhibition of lysosomal enzyme activities by proton pump inhibitors. J Gastroenterol. 2013;48(12):1343\u201352.","journal-title":"J Gastroenterol"},{"issue":"6","key":"926_CR89","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/nep.12226","volume":"19","author":"L Berney-Meyer","year":"2014","unstructured":"Berney-Meyer L, Hung N, Slatter T, Schollum JB, Kitching AR, Walker RJ. Omeprazole-induced acute interstitial nephritis: a possible Th1-Th17-mediated injury? Nephrology (Carlton). 2014;19(6):359\u201365.","journal-title":"Nephrology (Carlton)"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-020-00926-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-020-00926-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-020-00926-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T07:37:55Z","timestamp":1625125075000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-020-00926-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,10]]},"references-count":89,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1007\/s11882-020-00926-4","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,10]]},"assertion":[{"value":"10 June 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This work was prepared as part of the official duties of Drs. Pasman, Witmer, Ong, and Nylund, who are employed by the United States Navy, Army, and Air Force. The views expressed in this article are those of the authors and do not reflect the official policy or position of the United States Navy, Army, Air Force, Department of Defense, The Uniformed Services of the Health Sciences or the United States Government.The authors declare no conflicts of interest relevant to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"39"}}